Global Tissue Engineering-based Regeneration Products Market

Report ID : 1355 | Published : 2022-08-24 | Pages: | Format: PDF/EXCEL

The Global Tissue Engineering-based Regeneration Products market is projected to grow at a compound annual growth rate (CAGR) of 33.7% from 2022 to 2030. Integrating scaffolds, cells, and biologically active chemicals to create functioning tissues is referred to as tissue engineering. Tissue engineering emerged from the field of biomaterials development and referred to the practice. Tissue engineering aims to put together functional constructions to repair, maintain, or otherwise improve entire organs or damaged tissues. It is a large field that includes tissue engineering but also incorporates research on self-healing, when the body uses its systems, sometimes with the help of foreign biological material, to recreate cells and rebuild tissues and organs. Regenerative medicine is one of the more recent developments in the field of medicine. Many complex and more sophisticated tissue reconstructions have been successfully performed thanks to a novel technology. This indicates that more complex tissue engineering treatments may be conceivable in the near future. The market for tissue engineering will likely experience significant growth in the near future as a result of the rapid pace of innovation that is currently taking place in this sector, as well as the recent shift in consumer preference away from conventional transplant procedures and toward regeneration products that are based on tissue engineering.

Developments in stem cell technology and tissue engineering, an increase in the number of clinical studies for regenerative medicine and tissue engineering, and rising financing for tissue engineering research are all factors that are propelling the industry forward. Chronic diseases, including CVD, cancer, diabetes, ulcers, and genetic disorders like cystic fibrosis, have grown substantially in recent decades. Diabetes and obesity can increase the prevalence and complexity of wounds such as infections, ulcerations (leg or foot ulcers), and surgical wounds, requiring costly therapies, which will turn into high demand for engineered regenerative products, pushing the market upside.

While some Tissue Engineering-based Regeneration Products show promise as an alternative to organ donation, they are not yet generally used due to their prohibitively high prices and the difficulties in obtaining reimbursements and insurance coverage. An inability to educate patients is another potential growth-limiting factor in the years ahead. Scaffolds have issues that include infections, mechanical failure, and immunogenic reactions to implanted materials. The expansion of the market will be stunted as a result.

The Tissue Engineering-based Regeneration Products Market is categorized into four segments Type of Grafts, area of application, type of material scaffold and type of end-user. By type of graft, it is segmented into allografts, autografts and xenografts. Whereas area of application includes bone healing, burn Healing, Surgical Healing, Wound Healing, and Others. In the case of a type of material scaffold, the segment contains Bone Tissue, Collagen-based Tissue, Human Placental Tissue, Other Animal Based Tissue, Other Human Tissue, Stem Cells and Others Tissues. In the end, the fourth category is end-user, which consists of Ambulatory Surgical Centers, Hospitals and Specialty Clinics.

By the region, North America will lead the Tissue Engineering-based Regeneration Products Market in the forecasting period 2022-2030 as the funding and government investment are increasing continuously.

The prominent market companies are AlloSource, BioTissue, Integra Lifesciences Corporation , MiMedx, Organogenesis, Inc., Smith +Nephew, Tissue Regenix, VIVEX Biologics, Alliqua BioMedical, Inc., MISONIX, Inc., Arthrex, Inc., B. Braun Melsungen AG, BARD, A Becton, Dickinson Company, ConMed Corporation, Globus Medical, Inc., Lattice Biologics Ltd., Osiris Therapeutics, Inc., Straumann, Xtant Medical, and Zimmer Biomet Holdings, Inc. 

 

  • AlloSource
  • BioTissue
  • Integra Lifesciences Corporation
  • MiMedx
  • Organogenesis, Inc.
  • Smith +Nephew
  • Tissue Regenix
  • VIVEX Biologics
  • Alliqua BioMedical, Inc.
  • MISONIX, Inc.
  • Arthrex, Inc.
  • Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • ConMed Corporation
  • Globus Medical, Inc.
  • Lattice Biologics Ltd.
  • Osiris Therapeutics, Inc.
  • Straumann
  • Xtant Medical
  • Zimmer Biomet Holdings, Inc.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Tissue Engineering-based Regeneration Products Market Snapshot

Chapter 4. Global Tissue Engineering-based Regeneration Products Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Type of Graft Estimates & Trend Analysis

5.1. By Type of Graft & Market Share, 2022 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Type of Graft:

5.2.1. Allografts

5.2.2. Autografts

5.2.3. Xenografts

Chapter 6. Market Segmentation 2: By Area of Application Estimates & Trend Analysis

6.1. By Area of Application & Market Share, 2022 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Area of Application:

6.2.1. Bone Healing

6.2.2. Burn Healing

6.2.3. Surgical Healing

6.2.4. Wound Healing

6.2.5. Others

Chapter 7. Market Segmentation 3: By Type of Material Scaffold Estimates & Trend Analysis

7.1. By Type of Material Scaffold & Market Share, 2022 & 2030

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Type of Material Scaffold:

7.2.1. Bone Tissue

7.2.2. Collagen-based Tissue

7.2.3. Human Placental Tissue

7.2.4. Other Animal Based Tissue

7.2.5. Other Human Tissue

7.2.6. Stem Cell

7.2.7. Others Tissues

Chapter 8. Market Segmentation 4: By End-user Estimates & Trend Analysis

8.1. By End-user & Market Share, 2022 & 2030

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By End-user:

8.2.1. Ambulatory Surgical Centers

8.2.2. Hospitals

8.2.3. Specialty Clinics

Chapter 9. Tissue Engineering-based Regeneration Products Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Tissue Engineering-based Regeneration Products Market revenue (US$ Million) estimates and forecasts By Type of Graft, 2022-2030

9.1.2. North America Tissue Engineering-based Regeneration Products Market revenue (US$ Million) estimates and forecasts By Area of Application, 2022-2030

9.1.3. North America Tissue Engineering-based Regeneration Products Market revenue (US$ Million) estimates and forecasts by Type of Material Scaffold, 2022-2030

9.1.4. North America Tissue Engineering-based Regeneration Products Market revenue (US$ Million) estimates and forecasts by End-user, 2022-2030

9.1.5. North America Tissue Engineering-based Regeneration Products Market revenue (US$ Million) estimates and forecasts by country, 2022-2030

9.2. Europe

9.2.1. Europe Tissue Engineering-based Regeneration Products Market revenue (US$ Million) By Type of Graft, 2022-2030

9.2.2. Europe Tissue Engineering-based Regeneration Products Market revenue (US$ Million) By Area of Application, 2022-2030

9.2.3. Europe Tissue Engineering-based Regeneration Products Market revenue (US$ Million) estimates and forecasts by Type of Material Scaffold, 2022-2030

9.2.4. Europe Tissue Engineering-based Regeneration Products Market revenue (US$ Million) estimates and forecasts by End-user, 2022-2030

9.2.5. Europe Tissue Engineering-based Regeneration Products Market revenue (US$ Million) by country, 2022-2030

9.3. Asia Pacific

9.3.1. Asia Pacific Tissue Engineering-based Regeneration Products Market revenue (US$ Million) By Type of Graft, 2022-2030

9.3.2. Asia Pacific Tissue Engineering-based Regeneration Products Market revenue (US$ Million) By Area of Application, 2022-2030

9.3.3. Asia Pacific Tissue Engineering-based Regeneration Products Market revenue (US$ Million) estimates and forecasts by Type of Material Scaffold, 2022-2030

9.3.4. Asia Pacific Tissue Engineering-based Regeneration Products Market revenue (US$ Million) estimates and forecasts by End-user, 2022-2030

9.3.5. Asia Pacific Tissue Engineering-based Regeneration Products Market revenue (US$ Million) by country, 2022-2030

9.4. Latin America

9.4.1. Latin America Tissue Engineering-based Regeneration Products Market revenue (US$ Million) By Type of Graft, (US$ Million)

9.4.2. Latin America Tissue Engineering-based Regeneration Products Market revenue (US$ Million) By Area of Application, (US$ Million)

9.4.3. Latin America Tissue Engineering-based Regeneration Products Market revenue (US$ Million) estimates and forecasts by Type of Material Scaffold, 2022-2030

9.4.4. Latin America Tissue Engineering-based Regeneration Products Market revenue (US$ Million) estimates and forecasts by End-user, 2022-2030

9.4.5. Latin America Tissue Engineering-based Regeneration Products Market revenue (US$ Million) by country, 2022-2030

9.5. Middle East & Africa

9.5.1. Middle East & Africa Tissue Engineering-based Regeneration Products Market revenue (US$ Million) By Type of Graft, (US$ Million)

9.5.2. Middle East & Africa Tissue Engineering-based Regeneration Products Market revenue (US$ Million) By Area of Application, (US$ Million)

9.5.3. Middle East & Africa Tissue Engineering-based Regeneration Products Market revenue (US$ Million) estimates and forecasts by Type of Material Scaffold, 2022-2030

9.5.4. Middle East & Africa Tissue Engineering-based Regeneration Products Market revenue (US$ Million) estimates and forecasts by End-user, 2022-2030

9.5.5. Middle East & Africa Tissue Engineering-based Regeneration Products Market revenue (US$ Million) by country, 2022-2030

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. AlloSource

10.2.2. BioTissue

10.2.3. Integra Lifesciences Corporation

10.2.4. MiMedx

10.2.5. Organogenesis, Inc.

10.2.6. Smith +Nephew

10.2.7. Tissue Regenix

10.2.8. VIVEX Biologics

10.2.9. Alliqua BioMedical, Inc.

10.2.10. MISONIX, Inc.

10.2.11. Arthrex, Inc.

10.2.12. B. Braun Melsungen AG

10.2.13. BARD, A Becton, Dickinson Company

10.2.14. ConMed Corporation

10.2.15. Globus Medical, Inc.

10.2.16. Lattice Biologics Ltd.

10.2.17. Osiris Therapeutics, Inc.

10.2.18. Straumann

10.2.19. Xtant Medical

10.2.20. Zimmer Biomet Holdings, Inc.

10.2.21. Other Prominent Players

Global Tissue Engineering-based Regeneration Products  Market, by Type of Graft, 2022-2030 (Value US$ Mn)

  • Allografts
  • Autografts
  • Xenografts

Global Tissue Engineering-based Regeneration Products  Market, by Area of Application, 2022-2030 (Value US$ Mn)

  • Bone Healing
  • Burn Healing
  • Surgical Healing
  • Wound Healing
  • Others

Global Tissue Engineering-based Regeneration Products  Market, by Type of Material Scaffold, 2022-2030 (Value US$ Mn)

  • Bone Tissue
  • Collagen-based Tissue
  • Human Placental Tissue
  • Other Animal Based Tissue,
  • Other Human Tissue
  • Stem Cell
  • Others Tissues

Global Tissue Engineering-based Regeneration Products  Market, by Type of End-User, 2022-2030 (Value US$ Mn)

  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics 

Global Tissue Engineering-based Regeneration Products  Market, by Region, 2022-2030 (Value US$ Mn)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Tissue Engineering-based Regeneration Products  Market, by Country, 2022-2030 (Value US$ Mn)

  • U.S.
  • Canada

Europe Tissue Engineering-based Regeneration Products  Market, by Country, 2022-2030 (Value US$ Mn)

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

 

Asia Pacific Tissue Engineering-based Regeneration Products  Market, by Country, 2022-2030 (Value US$ Mn)

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand 

Latin America Tissue Engineering-based Regeneration Products  Market, by Country, 2022-2030 (Value US$ Mn)

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Tissue Engineering-based Regeneration Products  Market, by Country, 2022-2030 (Value US$ Mn)

  • GCC Countries
  • South Africa

Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients